Coverage of highly active antiretroviral therapy among postpartum women in Malawi

J. Kumwenda, F. Matchere, R. Mataya, S. Chen, L. Mipando, Q. Li, N. I. Kumwenda, Taha E Taha

Research output: Contribution to journalArticle

Abstract

Summary: The expanding services of antiretroviral treatment (ART) in sub-Saharan Africa provide unique opportunities to reduce HIV/AIDS-related morbidity and mortality. In these settings, HIV prevalence among antenatal women remains high and treating eligible pregnant or breastfeeding women with antiretrovirals can substantially reduce transmission of HIV from the mother to her infant. However, identification of women eligible for treatment and ensuring access to ART services is challenging. In this analysis, we used data from a large clinical trial (the PEPI-Malawi study, 2004-09) to prevent mother-to-child transmission of HIV through extended antiretroviral prophylaxis of infants to examine barriers for wider coverage with highly active antiretroviral treatment (HAART) of postpartum women. Maternal HAART was not part of the original PEPI-Malawi clinical trial but became available through a government programme during the course of the study. Therefore, eligible women (CD4 cell count

Original languageEnglish (US)
Pages (from-to)368-372
Number of pages5
JournalInternational Journal of STD and AIDS
Volume22
Issue number7
DOIs
Publication statusPublished - Jul 2011

    Fingerprint

Keywords

  • Access
  • Antiretroviral therapy
  • Coverage
  • HAART
  • HIV
  • Malawi
  • Mother-to-child transmission
  • Postpartum women
  • Treatment

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)
  • Infectious Diseases

Cite this